Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile | table of contents
Lev Pharmaceuticals Inc - Premium Company Profile (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 22/04/2008
- Report Title: Lev Pharmaceuticals Inc - Premium Company Profile
- View Report Summary: View Report Summary
- Report Type: Company Profile
- Country: Global
- Number of Pages: 34
Overview 1
Catalyst 1
Summary 1
Table of Contents 2
Table of figures 3
Table of tables 4
Company Structure 5
Company Overview and Key Facts 5
Business Description 6
Landmark Products and Services 6
C1-INH technology 6
History 7
Company Financials 9
Stock Market Performance 9
P&L 10
Balance Sheet 12
Cash Flow 12
Products & Services 13
Pipeline Products 13
In-house Pipeline 13
Cinryze 13
C1-INH 13
AC Forecast Product Sales 14
Competitors and Strategic Business Relationships 15
Key Competitors 15
Key Suppliers 15
Shareholding Structure 16
Strategy 17
Corporate Strategy 17
SWOT Analysis 18
Overview 18
Strengths 19
C1-INH technology 19
Weaknesses 20
Inability to raise additional funds in capital markets 20
Opportunities 21
Cinryze 21
Additional indication of C1-INH 21
Threats 22
Hurdles in launching Cinryze 22
Uncertainty over market acceptance 22
Value Chain Analysis 23
Overview 23
Product Development 23
Sales 23
Scorecard 24
Overview 24
Scorecard Analysis 24
Key Employees 25
List of Key Employees 25
Key Employee Biographies 26
Joshua D Schein 26
Judson Cooper 26
Henry M Dachowitz 27
Scott Eagle 27
Thomas Lanier 28
Eric I Richman 28
Douglas J Beck 29
Matt Duffy 29
Jason Bablak 29
Bart Jones 30
Ira N Kalfus 30
Joseph Truitt 30
Financial and Operational Overview 31
Financial and Operational Overview 31
APPENDIX 33
Ask the analyst 33
Datamonitor consulting 33
Disclaimer 33
List of Tables
Table 1: Lev Pharmaceuticals- Key Facts 5
Table 2: Lev Pharmaceuticals- Year-End Share Price and Market Capitalization, 2002-2006 ($) 9
Table 3: Lev Pharmaceuticals- Key Events Impacting Share Price Performance 9
Table 4: Lev Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 10
Table 5: Lev Pharmaceuticals- Balance Sheet 12
Table 6: Lev Pharmaceuticals- Cash Flow 12
Table 7: Lev Pharmaceuticals- In-house Pipeline Products 13
Table 8: Lev Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn) 14
Table 9: Lev Pharmaceuticals- Key Competitors 15
Table 10: Lev Pharmaceuticals- Key Suppliers 15
Table 11: Lev Pharmaceuticals- Key Shareholders 16
Table 12: Lev Pharmaceuticals- SWOT Analysis Summary 18
Table 13: Lev Pharmaceuticals- Value Chain Analysis 23
Table 14: Lev Pharmaceuticals- Key Employees 25
Table 15: Lev Pharmaceuticals - Financial and Operational Overview 31
List of Figures
Figure 1: Lev Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 11
Catalyst 1
Summary 1
Table of Contents 2
Table of figures 3
Table of tables 4
Company Structure 5
Company Overview and Key Facts 5
Business Description 6
Landmark Products and Services 6
C1-INH technology 6
History 7
Company Financials 9
Stock Market Performance 9
P&L 10
Balance Sheet 12
Cash Flow 12
Products & Services 13
Pipeline Products 13
In-house Pipeline 13
Cinryze 13
C1-INH 13
AC Forecast Product Sales 14
Competitors and Strategic Business Relationships 15
Key Competitors 15
Key Suppliers 15
Shareholding Structure 16
Strategy 17
Corporate Strategy 17
SWOT Analysis 18
Overview 18
Strengths 19
C1-INH technology 19
Weaknesses 20
Inability to raise additional funds in capital markets 20
Opportunities 21
Cinryze 21
Additional indication of C1-INH 21
Threats 22
Hurdles in launching Cinryze 22
Uncertainty over market acceptance 22
Value Chain Analysis 23
Overview 23
Product Development 23
Sales 23
Scorecard 24
Overview 24
Scorecard Analysis 24
Key Employees 25
List of Key Employees 25
Key Employee Biographies 26
Joshua D Schein 26
Judson Cooper 26
Henry M Dachowitz 27
Scott Eagle 27
Thomas Lanier 28
Eric I Richman 28
Douglas J Beck 29
Matt Duffy 29
Jason Bablak 29
Bart Jones 30
Ira N Kalfus 30
Joseph Truitt 30
Financial and Operational Overview 31
Financial and Operational Overview 31
APPENDIX 33
Ask the analyst 33
Datamonitor consulting 33
Disclaimer 33
List of Tables
Table 1: Lev Pharmaceuticals- Key Facts 5
Table 2: Lev Pharmaceuticals- Year-End Share Price and Market Capitalization, 2002-2006 ($) 9
Table 3: Lev Pharmaceuticals- Key Events Impacting Share Price Performance 9
Table 4: Lev Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 10
Table 5: Lev Pharmaceuticals- Balance Sheet 12
Table 6: Lev Pharmaceuticals- Cash Flow 12
Table 7: Lev Pharmaceuticals- In-house Pipeline Products 13
Table 8: Lev Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn) 14
Table 9: Lev Pharmaceuticals- Key Competitors 15
Table 10: Lev Pharmaceuticals- Key Suppliers 15
Table 11: Lev Pharmaceuticals- Key Shareholders 16
Table 12: Lev Pharmaceuticals- SWOT Analysis Summary 18
Table 13: Lev Pharmaceuticals- Value Chain Analysis 23
Table 14: Lev Pharmaceuticals- Key Employees 25
Table 15: Lev Pharmaceuticals - Financial and Operational Overview 31
List of Figures
Figure 1: Lev Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 11
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
